GGrantIndex
← Leaderboards

Philip D King

University Of Michigan At Ann Arbor

$12,120,681
Attributed
$13,924,086
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,924,086 · 9

By mechanism

R01$13,067,138 · 7
R21$856,948 · 2

Top collaborators

Others in their field

Top investigators on “Cells

Research focus

CellsLaboratoriesSignal TransductionBloodMolecularReportingGenesGeneticGrowth Factor ReceptorsBurden Of IllnessUnited States National Institutes Of HealthInnovationDisabilityMissionLifeRas Signaling PathwayVascular DiseasesCell TypeCessation Of LifeMutationLeadMouse ModelLymphatic VesselPublic Health

Grant awards (36)

Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells$642,522
R01 · FY2025 · AI
A Novel Mechanism of Ras Regulation Necessary for Normal Vascular Development$597,722
R01 · FY2025 · NS · contact PI
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells$642,522
R01 · FY2024 · AI
EPHB4-RASA1 regulation of lymphatic vessel valve development and function$568,021
R01 · FY2024 · HL · contact PI
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells$642,522
R01 · FY2023 · AI
EPHB4-RASA1 regulation of lymphatic vessel valve development and function$571,152
R01 · FY2023 · HL · contact PI
Molecular pathogenetic mechanisms in CM-AVM$518,808
R01 · FY2023 · HL · contact PI
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells$652,522
R01 · FY2022 · AI
EPHB4-RASA1 regulation of lymphatic vessel valve development and function$616,353
R01 · FY2022 · HL · contact PI
Molecular pathogenetic mechanisms in CM-AVM$518,808
R01 · FY2022 · HL · contact PI
The Structure and Function of Dental Lymphatics (R21)$234,000
R21 · FY2022 · DE
EPHB4-RASA1 regulation of lymphatic vessel valve development and function$667,291
R01 · FY2021 · HL · contact PI
Molecular pathogenetic mechanisms in CM-AVM$518,808
R01 · FY2021 · HL · contact PI
The Structure and Function of Dental Lymphatics (R21)$195,000
R21 · FY2021 · DE
Molecular pathogenetic mechanisms in CM-AVM$603,208
R01 · FY2020 · HL · contact PI
Lymphatic Vessel Abnormalities in CM-AVM$386,621
R01 · FY2018 · HL · contact PI
Lymphatic Vessel Abnormalities in CM-AVM$386,635
R01 · FY2017 · HL · contact PI
Lymphatic Vessel Abnormalities in CM-AVM$390,645
R01 · FY2016 · HL · contact PI
Lymphatic Vessel Abnormalities in CM-AVM$397,172
R01 · FY2015 · HL · contact PI
Random Monoallelic Expression and Human Disease$228,298
R21 · FY2015 · HD · contact PI
Random Monoallelic Expression and Human Disease$199,650
R21 · FY2014 · HD · contact PI
RASA1-mediated control of lymphatic vessel growth and function$353,279
R01 · FY2012 · HL · contact PI
RASA1-mediated control of lymphatic vessel growth and function$357,690
R01 · FY2011 · HL · contact PI
RASA1-mediated control of lymphatic vessel growth and function$358,507
R01 · FY2010 · HL · contact PI
RASA1-mediated control of lymphatic vessel growth and function$372,925
R01 · FY2009 · HL · contact PI
Control of T cell activation by the TSAd adapter protein$283,528
R01 · FY2006 · AI · contact PI
Control of T cell activation by the TSAd adapter protein$290,806
R01 · FY2005 · AI
Control of T cell activation by the TSAd adapter protein$281,862
R01 · FY2004 · AI
Control of T cell activation by the TSAd adapter protein$290,881
R01 · FY2003 · AI
REGULATION OF CD28 SIGNAL TRNSDUCTION$231,602
R01 · FY2003 · AI
REGULATION OF CD28 SIGNAL TRNSDUCTION$178,523
R01 · FY2002 · AI
Control of T cell activation by the TSAd adapter protein$161,834
R01 · FY2002 · AI
Control of T cell activation by the TSAd adapter protein$139,494
R01 · FY2002 · AI
REGULATION OF CD28 SIGNAL TRNSDUCTION$33,045
R01 · FY2002 · AI
REGULATION OF CD28 SIGNAL TRNSDUCTION$208,957
R01 · FY2001 · AI
REGULATION OF CD28 SIGNAL TRNSDUCTION$202,873
R01 · FY2000 · AI